Sign in
Cancer BiologybioRxiv

The solute carrier MFSD1 decreases β1 integrins activation status and thus tumor metastasis

M. Roblek, J. Bicher, M. van Gogh, A. Gyoergy, R. Seeboeck, B. Szulc, M. Damme, M. Olczak, L. Borsig, D. Siekhaus

Abstract

Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier MFSD1 in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in a mouse model. We identified an increased migratory potential in MFSD1-/- tumor cells which was mediated by increased focal adhesion turn-over, reduced stability of mature inactive {beta}1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive {beta}1 integrin and thereby protected {beta}1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, down-regulation of MFSD1 expression was observed during early steps of tumorigenesis and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient {beta}1 integrin recycling to suppress tumor spread.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISLlanses '24Lau '20Mohr '20Galifi '26Noshita '23Benito-Mart '22
65% semantic matchCancer Biology
Montserrat Llanses, Keqian Nan, Zhe Bao+6 more·PLoS Biology·Dec 12, 2024· 15 citations